Talex S.A. (TLX) - Net Assets
Based on the latest financial reports, Talex S.A. (TLX) has net assets worth zł53.09 Million PLN (≈ $14.61 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł75.38 Million ≈ $20.75 Million USD) and total liabilities (zł22.30 Million ≈ $6.14 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Talex S.A. (TLX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł53.09 Million |
| % of Total Assets | 70.42% |
| Annual Growth Rate | 0.81% |
| 5-Year Change | 10.33% |
| 10-Year Change | 9.65% |
| Growth Volatility | 6.48 |
Talex S.A. - Net Assets Trend (2008–2025)
This chart illustrates how Talex S.A.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Talex S.A. market cap and net worth.
Annual Net Assets for Talex S.A. (2008–2025)
The table below shows the annual net assets of Talex S.A. from 2008 to 2025. Also explore Talex S.A. (TLX) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | zł54.43 Million ≈ $14.98 Million |
+7.25% |
| 2024-12-31 | zł50.75 Million ≈ $13.97 Million |
-3.46% |
| 2023-12-31 | zł52.57 Million ≈ $14.47 Million |
+2.91% |
| 2022-12-31 | zł51.09 Million ≈ $14.06 Million |
+3.54% |
| 2021-12-31 | zł49.34 Million ≈ $13.58 Million |
-12.54% |
| 2020-12-31 | zł56.41 Million ≈ $15.52 Million |
+3.34% |
| 2019-12-31 | zł54.59 Million ≈ $15.02 Million |
-0.95% |
| 2018-12-31 | zł55.11 Million ≈ $15.17 Million |
+5.71% |
| 2017-12-31 | zł52.14 Million ≈ $14.35 Million |
+5.02% |
| 2016-12-31 | zł49.64 Million ≈ $13.66 Million |
+1.85% |
| 2015-12-31 | zł48.74 Million ≈ $13.41 Million |
+0.27% |
| 2014-12-31 | zł48.61 Million ≈ $13.38 Million |
+9.67% |
| 2013-12-31 | zł44.32 Million ≈ $12.20 Million |
+9.99% |
| 2012-12-31 | zł40.29 Million ≈ $11.09 Million |
-6.39% |
| 2011-12-31 | zł43.04 Million ≈ $11.85 Million |
-1.91% |
| 2010-12-31 | zł43.88 Million ≈ $12.08 Million |
+5.39% |
| 2009-12-31 | zł41.64 Million ≈ $11.46 Million |
-12.19% |
| 2008-12-31 | zł47.42 Million ≈ $13.05 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Talex S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | zł4.43 Million | 8.14% |
| Common Stock | zł3.00 Million | 5.51% |
| Other Components | zł47.00 Million | 86.35% |
| Total Equity | zł54.43 Million | 100.00% |
Talex S.A. Competitors by Market Cap
The table below lists competitors of Talex S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HWH International Inc
NASDAQ:HWH
|
$14.37 Million |
|
Peruvian Metals Corp
V:PER
|
$14.37 Million |
|
Agat Ejendomme A/S
CO:AGAT
|
$14.37 Million |
|
Episurf Medical AB (publ)
ST:EPIS-B
|
$14.37 Million |
|
Donegal Investment Group PLC
IR:DQ7A
|
$14.36 Million |
|
Anugerah Kagum Karya Utama Tbk PT
JK:AKKU
|
$14.36 Million |
|
Neuroscientific Biopharmaceuticals Ltd
AU:NSB
|
$14.35 Million |
|
Australian Agricultural Projects Ltd
AU:AAP
|
$14.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Talex S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 50,754,000 to 54,434,000, a change of 3,680,000 (7.3%).
- Net income of 4,430,000 contributed positively to equity growth.
- Dividend payments of 750,000 reduced retained earnings.
- Other comprehensive income decreased equity by 27,874,000.
- Other factors increased equity by 27,874,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł4.43 Million | +8.14% |
| Dividends Paid | zł750.00K | -1.38% |
| Other Comprehensive Income | zł-27.87 Million | -51.21% |
| Other Changes | zł27.87 Million | +51.21% |
| Total Change | zł- | 7.25% |
Book Value vs Market Value Analysis
This analysis compares Talex S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.96x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.10x to 0.96x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | zł15.77 | zł17.40 | x |
| 2009-12-31 | zł13.88 | zł17.40 | x |
| 2010-12-31 | zł14.66 | zł17.40 | x |
| 2011-12-31 | zł14.35 | zł17.40 | x |
| 2012-12-31 | zł13.43 | zł17.40 | x |
| 2013-12-31 | zł14.77 | zł17.40 | x |
| 2014-12-31 | zł16.20 | zł17.40 | x |
| 2015-12-31 | zł16.25 | zł17.40 | x |
| 2016-12-31 | zł16.55 | zł17.40 | x |
| 2017-12-31 | zł17.38 | zł17.40 | x |
| 2018-12-31 | zł18.37 | zł17.40 | x |
| 2019-12-31 | zł18.20 | zł17.40 | x |
| 2020-12-31 | zł18.80 | zł17.40 | x |
| 2021-12-31 | zł16.45 | zł17.40 | x |
| 2022-12-31 | zł17.03 | zł17.40 | x |
| 2023-12-31 | zł17.52 | zł17.40 | x |
| 2024-12-31 | zł16.92 | zł17.40 | x |
| 2025-12-31 | zł18.18 | zł17.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Talex S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.14%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.38%
- • Asset Turnover: 1.65x
- • Equity Multiplier: 1.46x
- Recent ROE (8.14%) is above the historical average (5.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 8.50% | 3.07% | 1.45x | 1.91x | zł-711.51K |
| 2009 | -6.68% | -4.49% | 1.15x | 1.29x | zł-6.94 Million |
| 2010 | 5.11% | 2.12% | 1.63x | 1.48x | zł-2.14 Million |
| 2011 | 1.54% | 0.46% | 2.05x | 1.62x | zł-3.64 Million |
| 2012 | -5.34% | -2.27% | 1.43x | 1.64x | zł-6.18 Million |
| 2013 | 13.41% | 5.08% | 1.59x | 1.66x | zł1.51 Million |
| 2014 | 17.85% | 7.89% | 1.29x | 1.75x | zł3.81 Million |
| 2015 | 12.82% | 5.04% | 1.17x | 2.18x | zł1.38 Million |
| 2016 | 9.51% | 4.18% | 1.15x | 1.98x | zł-244.40K |
| 2017 | 10.99% | 5.31% | 1.16x | 1.79x | zł517.20K |
| 2018 | 11.93% | 6.94% | 1.01x | 1.70x | zł1.06 Million |
| 2019 | 4.40% | 2.71% | 1.07x | 1.53x | zł-3.05 Million |
| 2020 | 6.42% | 3.74% | 1.15x | 1.50x | zł-2.02 Million |
| 2021 | -10.08% | -6.78% | 1.05x | 1.42x | zł-9.91 Million |
| 2022 | 3.42% | 2.14% | 1.07x | 1.49x | zł-3.36 Million |
| 2023 | 2.83% | 1.80% | 1.06x | 1.48x | zł-3.77 Million |
| 2024 | 1.74% | 1.22% | 1.06x | 1.34x | zł-4.19 Million |
| 2025 | 8.14% | 3.38% | 1.65x | 1.46x | zł-1.01 Million |
Industry Comparison
This section compares Talex S.A.'s net assets metrics with peer companies in the Information Technology Services industry.
Industry Context
- Industry: Information Technology Services
- Average net assets among peers: $86,043,904
- Average return on equity (ROE) among peers: 14.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Talex S.A. (TLX) | zł53.09 Million | 8.50% | 0.42x | $14.37 Million |
| Ailleron S.A. (ALL) | $55.31 Million | 12.74% | 0.58x | $51.55 Million |
| Atende S.A. (ATD) | $75.08 Million | 1.75% | 1.18x | $45.91 Million |
| Betacom S.A. (BCM) | $21.06 Million | 12.14% | 1.74x | $5.74 Million |
| Comp SA (CMP) | $309.76 Million | 5.50% | 0.46x | $513.25 Million |
| IFirma SA (IFI) | $13.72 Million | 54.40% | 0.61x | $38.93 Million |
| OpTeam S.A. (OPM) | $21.95 Million | 9.54% | 1.90x | $12.89 Million |
| Passus S.A. (PAS) | $22.27 Million | 7.28% | 2.18x | $86.64 Million |
| Sygnity SA (SGN) | $169.21 Million | 15.94% | 0.67x | $522.93 Million |
About Talex S.A.
Talex S.A. provides IT services in Poland. The company offers data centers, such as collocation, cloud computing, and business continuity; and isolated recovery, IT outsourcing, software development, and IT infrastructure integration services. It serves e-commerce, automotive, and the financial sectors. Talex S.A. was founded in 1989 and is headquartered in Poznan, Poland.